Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (11-20 of 17,044) with videos related to

Pageof 1,705
Sort By:
Cancer Letters|March 24, 2020
Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunitiesAshish Kumar, Gagan Deep
Cancer Letters|January 21, 2020
Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinomaTatevik R Broutian, Bo Jiang, Jingfeng Li, et al.
Cancer Letters|September 13, 2020
Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infectionRong Lin, Chaoqun Han, Zhen Ding, et al.
Cancer Letters|July 1, 1988
DNA viruses and human cancerS J Fey, P M Larsen
Cancer Letters|March 30, 2020
MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myelomaLun Zhang, Nasrin Rastgoo, Jian Wu, et al.
Cancer Letters|March 30, 2020
Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 betaXin Liang, Wei Guo, Tingting Ren, et al.
Cancer Letters|July 15, 2021
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modificationsYingxue Gao, Yijun Liu, Youhong Liu, et al.
Cancer Letters|June 14, 2021
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoidsVivien Koh, Jayati Chakrabarti, Meaghan Torvund, et al.
Cancer Letters|July 6, 2021
miR-125a-5p impairs the metastatic potential in breast cancer via IP<sub>6</sub>K1 targetingMirko Minini, Alice Senni, Xingkang He, et al.
Cancer Letters|July 10, 2021
Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosisWen Zhao, Danlei Yu, Zhen Chen, et al.
Pageof 1,705

Showing results (11-20 of 17,044) with videos related to

Sort By:
Pageof 1,705
Cancer Letters|March 24, 2020
Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunitiesAshish Kumar, Gagan Deep
Cancer Letters|January 21, 2020
Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinomaTatevik R Broutian, Bo Jiang, Jingfeng Li, et al.
Cancer Letters|September 13, 2020
Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infectionRong Lin, Chaoqun Han, Zhen Ding, et al.
Cancer Letters|July 1, 1988
DNA viruses and human cancerS J Fey, P M Larsen
Cancer Letters|March 30, 2020
MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myelomaLun Zhang, Nasrin Rastgoo, Jian Wu, et al.
Cancer Letters|March 30, 2020
Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 betaXin Liang, Wei Guo, Tingting Ren, et al.
Cancer Letters|July 15, 2021
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modificationsYingxue Gao, Yijun Liu, Youhong Liu, et al.
Cancer Letters|June 14, 2021
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoidsVivien Koh, Jayati Chakrabarti, Meaghan Torvund, et al.
Cancer Letters|July 6, 2021
miR-125a-5p impairs the metastatic potential in breast cancer via IP<sub>6</sub>K1 targetingMirko Minini, Alice Senni, Xingkang He, et al.
Cancer Letters|July 10, 2021
Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosisWen Zhao, Danlei Yu, Zhen Chen, et al.
Pageof 1,705